Canada In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Published: August 2015
No. of Pages: 259
   

GlobalData''s new report, "Canada In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture", provides key market data on the Canada In Vitro Diagnostics market. The report provides value, in millions of US dollars within market segments - Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • In Vitro Diagnostics market includes Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.
  • Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for In Vitro Diagnostics market.
  • Global corporate-level profiles of key companies operating within the Canada In Vitro Diagnostics market.
  • Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Danaher Corporation, Ortho-Clinical Diagnostics Inc. Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. and Others.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what''s the most preferred mode of product distribution - Identify, understand and capitalize.

Canada In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Table of Contents

1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 8

2 Introduction 11
2.1 What Is This Report About? 11
2.2 In Vitro Diagnostics Market Segmentation 11
2.3 Definitions of Markets Covered in the Report 14

3 In Vitro Diagnostics Market, Canada 27
3.1 In Vitro Diagnostics Market, Canada, Revenue ($m), 2007-2021 27
3.2 In Vitro Diagnostics Market, Canada, Revenue Mix ($m), 2014 29
3.3 In Vitro Diagnostics Market, Canada, Category Contribution by Revenue ($m), 2014 30
3.4 In Vitro Diagnostics Market, Canada, Category Comparison by Revenue ($m), 2007-2021 31
3.5 In Vitro Diagnostics Market, Canada, Revenue ($m), 2007-2014 33
3.6 In Vitro Diagnostics Market, Canada, Revenue ($m), 2014-2021 35
3.7 In Vitro Diagnostics Market, Canada, Company Share by Revenue ($m), 2014 37

4 Clinical Chemistry Market, Canada 39
4.1 Clinical Chemistry Market, Canada, Revenue Mix ($m), 2014 39
4.2 Clinical Chemistry Market, Canada, Segment Contribution (%), 2014 40
4.3 Clinical Chemistry Market, Canada, Revenue ($m), 2007-2014 42
4.4 Clinical Chemistry Market, Canada, Revenue ($m), 2014-2021 44
4.5 Clinical Chemistry Market, Canada, Distribution Share by Revenue ($m), 2013-2014 58
4.6 Clinical Chemistry Market, Canada, Company Share by Revenue ($m), 2014 59

5 Genetic Testing Market, Canada 61
5.1 Genetic Testing Market, Canada, Revenue Mix ($m), 2014 61
5.2 Genetic Testing Market, Canada, Segment Contribution (%), 2014 62
5.3 Genetic Testing Market, Canada, Revenue ($m), 2007-2014 63
5.4 Genetic Testing Market, Canada, Revenue ($m), 2014-2021 65
5.5 Genetic Testing Market, Canada, Distribution Share by Revenue ($m), 2013-2014 67
5.6 Genetic Testing Market, Canada, Company Share by Revenue ($m), 2014 68

6 Haematology Market, Canada 70
6.1 Haematology Market, Canada, Revenue Mix ($m), 2014 70
6.2 Haematology Market, Canada, Segment Contribution (%), 2014 71
6.3 Haematology Market, Canada, Revenue ($m), 2007-2014 72
6.4 Haematology Market, Canada, Revenue ($m), 2014-2021 74
6.5 Haematology Market, Canada, Distribution Share by Revenue ($m), 2013-2014 96
6.6 Haematology Market, Canada, Company Share by Revenue ($m), 2014 97

7 Histology And Cytology Market, Canada 99
7.1 Histology And Cytology Market, Canada, Revenue Mix ($m), 2014 99
7.2 Histology And Cytology Market, Canada, Segment Contribution (%), 2014 100
7.3 Histology And Cytology Market, Canada, Revenue ($m), 2007-2014 101
7.4 Histology And Cytology Market, Canada, Revenue ($m), 2014-2021 103
7.5 Histology And Cytology Market, Canada, Distribution Share by Revenue ($m), 2013-2014 105
7.6 Histology And Cytology Market, Canada, Company Share by Revenue ($m), 2014 106

8 Immuno Chemistry Market, Canada 108
8.1 Immuno Chemistry Market, Canada, Revenue Mix ($m), 2014 108
8.2 Immuno Chemistry Market, Canada, Segment Contribution (%), 2014 109
8.3 Immuno Chemistry Market, Canada, Revenue ($m), 2007-2014 111
8.4 Immuno Chemistry Market, Canada, Revenue ($m), 2014-2021 113
8.5 Immuno Chemistry Market, Canada, Distribution Share by Revenue ($m), 2013-2014 143
8.6 Immuno Chemistry Market, Canada, Company Share by Revenue ($m), 2014 144

9 Infectious Diagnostics Market, Canada 146
9.1 Infectious Diagnostics Market, Canada, Revenue Mix ($m), 2014 146
9.2 Infectious Diagnostics Market, Canada, Segment Contribution (%), 2014 147
9.3 Infectious Diagnostics Market, Canada, Revenue ($m), 2007-2014 149
9.4 Infectious Diagnostics Market, Canada, Revenue ($m), 2014-2021 151
9.5 Infectious Diagnostics Market, Canada, Distribution Share by Revenue ($m), 2013-2014 157
9.6 Infectious Diagnostics Market, Canada, Company Share by Revenue ($m), 2014 158

10 Microbiology Culture Market, Canada 160
10.1 Microbiology Culture Market, Canada, Revenue Mix ($m), 2014 160
10.2 Microbiology Culture Market, Canada, Segment Contribution (%), 2014 161
10.3 Microbiology Culture Market, Canada, Revenue ($m), 2007-2014 162
10.4 Microbiology Culture Market, Canada, Revenue ($m), 2014-2021 164
10.5 Microbiology Culture Market, Canada, Distribution Share by Revenue ($m), 2013-2014 170
10.6 Microbiology Culture Market, Canada, Company Share by Revenue ($m), 2014 171

11 Overview of Key Companies in Canada, In Vitro Diagnostics Market 173
11.1 Siemens Healthcare 173
11.2 F. Hoffmann-La Roche Ltd. 173
11.3 Abbott Laboratories 173
11.4 bioMerieux S.A. 174
11.5 Danaher Corporation 174
11.6 Becton, Dickinson and Company 174
11.7 Qiagen N.V. 175
11.8 Hologic, Inc. 175
11.9 Immucor, Inc. 175
11.10 Bio-Rad Laboratories, Inc. 176
11.11 Ortho-Clinical Diagnostics Inc. 176
11.12 Thermo Fisher Scientific Inc. 176
11.13 Sysmex Corporation 177
11.14 Alere Inc. 177
11.15 PerkinElmer, Inc. 177

12 In Vitro Diagnostics Market Pipeline Products 178

13 Financial Deals Landscape 184
13.1 Acquisition 184
13.2 Asset Transactions 188
13.3 Debt Offerings 192
13.4 Equity Offerings 194
13.5 Partnerships 207
13.6 Venture Financing 248

14 Appendix 253
14.1 Research Methodology 254
14.2 GlobalData Consulting 255
14.3 Contact Us 255
14.4 Disclaimer 256

List of Tables

Table 1: In Vitro Diagnostics Market, Canada, Revenue ($m), USD Constant, 2007-2021 31
Table 2: In Vitro Diagnostics Market, Canada, Category Contribution by Revenue ($m), 2014 33
Table 3: In Vitro Diagnostics Market, Canada, Category Comparison by Revenue ($m), USD Constant, 2007-2021 35
Table 4: In Vitro Diagnostics Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 37
Table 5: In Vitro Diagnostics Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 39
Table 6: In Vitro Diagnostics Market, Canada, Company Share by Revenue ($m), USD Constant, 2014 41
Table 7: Clinical Chemistry Market, Canada, Segment Contribution (%), 2014 44
Table 8: Clinical Chemistry Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 46
Table 9: Clinical Chemistry Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 48
Table 10: Clinical Chemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 50
Table 11: Therapeutic Drug Monitoring Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 52
Table 12: Urine Analysis Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 54
Table 13: Clinical Chemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 56
Table 14: Therapeutic Drug Monitoring Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 58
Table 15: Urine Analysis Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 60
Table 16: Clinical Chemistry Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014 61
Table 17: Clinical Chemistry Market, Canada, Company Share by Revenue ($m), USD Constant, 2014 63
Table 18: Genetic Testing Market, Canada, Segment Contribution (%), 2014 65
Table 19: Genetic Testing Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 67
Table 20: Genetic Testing Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 69
Table 21: Genetic Testing Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014 70
Table 22: Genetic Testing Market, Canada, Company Share by Revenue ($m), USD Constant, 2014 72
Table 23: Haematology Market, Canada, Segment Contribution (%), 2014 74
Table 24: Haematology Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 76
Table 25: Haematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 78
Table 26: Haematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 80
Table 27: Haematology Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 82
Table 28: Haematology Reagents Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 84
Table 29: Haemostasis Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 86
Table 30: Immunohaematology Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 88
Table 31: Haematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 90
Table 32: Haematology Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 92
Table 33: Haematology Reagents Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 94
Table 34: Haemostasis Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 96
Table 35: Immunohaematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 98
Table 36: Haematology Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014 99
Table 37: Haematology Market, Canada, Company Share by Revenue ($m), USD Constant, 2014 101
Table 38: Histology And Cytology Market, Canada, Segment Contribution (%), 2014 103
Table 39: Histology And Cytology Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 105
Table 40: Histology And Cytology Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 107
Table 41: Histology And Cytology Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014 108
Table 42: Histology And Cytology Market, Canada, Company Share by Revenue ($m), USD Constant, 2014 110
Table 43: Immuno Chemistry Market, Canada, Segment Contribution (%), 2014 113
Table 44: Immuno Chemistry Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 115
Table 45: Immuno Chemistry Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 117
Table 46: Anemia Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 119
Table 47: Disease Specific Immunochemistry Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 121
Table 48: Endocrinology Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 123
Table 49: IgE Allergy Blood Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 125
Table 50: Immunochemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 127
Table 51: Immunochemistry Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 129
Table 52: Vitamins Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 131
Table 53: Anemia Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 133
Table 54: Disease Specific Immunochemistry Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 135
Table 55: Endocrinology Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 137
Table 56: IgE Allergy Blood Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 139
Table 57: Immunochemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 141
Table 58: Immunochemistry Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 143
Table 59: Vitamins Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 145
Table 60: Immuno Chemistry Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014 146
Table 61: Immuno Chemistry Market, Canada, Company Share by Revenue ($m), USD Constant, 2014 148
Table 62: Infectious Diagnostics Market, Canada, Segment Contribution (%), 2014 151
Table 63: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 153
Table 64: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 155
Table 65: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 157
Table 66: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 159
Table 67: Infectious Diagnostics Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014 160
Table 68: Infectious Diagnostics Market, Canada, Company Share by Revenue ($m), USD Constant, 2014 162
Table 69: Microbiology Culture Market, Canada, Segment Contribution (%), 2014 164
Table 70: Microbiology Culture Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 166
Table 71: Microbiology Culture Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 168
Table 72: Microbiology Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 170
Table 73: Microbiology Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 172
Table 74: Microbiology Culture Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014 173
Table 75: Microbiology Culture Market, Canada, Company Share by Revenue ($m), USD Constant, 2014 175
Table 76: In Vitro Diagnostics Market Pipeline Products 181
Table 77: OnSite Lab Invests USD1 Million in MedMira 187
Table 78: Canon Acquires Stake in Spartan Bioscience 188
Table 79: Empire Genomics Acquires ID Labs 189
Table 80: Sunrise to Acquire Event Cardio, Medical Device Company 190
Table 81: Valeant Pharma to Acquire Rights to IBSchek in US and Canada form Commonwealth Labs 191
Table 82: Xagenic Acquires Rights to Detection Technology from University of Toronto 192
Table 83: Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 193
Table 84: SQI Diagnostics Completes Second and Final Tranche of Private Placement of Debentures for USD1.3 Million 195
Table 85: GeneNews to Raise up to USD2.4 Million in Private Placement of Units 197
Table 86: Miraculins Raises USD0.28 Million in Private Placement of Units 198
Table 87: SQI Diagnostics Raises USD2.2 Million In in First Tranche of Private Placement of Shares 199
Table 88: Miraculins Raise USD0.32 Million in Private Placement of Units 200
Table 89: Spectral Diagnostics Raises USD4.7 Million in Second Tranche of Private Placement of Shares 201
Table 90: GeneNews Raises USD1 Million upon Exercise of Warrants 203
Table 91: Miraculins Raises USD0.17 Million in Private Placement of Units 204
Table 92: M Pharma Raises USD1 Million in Private Placement of Units 205
Table 93: Miraculins Raises USD1.2 Million in Private Placement of Units 206
Table 94: Zecotek Photonics Raises USD2.5 Million in First Tranche of Private Placement of Units 207
Table 95: ChroMedX Raises USD0.56 Million in Private Placement of Units 208
Table 96: Med BioGene to Raise USD0.2 Million in Private Placement of Units 209
Table 97: Sigma-Aldrich Enters into Distribution Agreement with LGC 210
Table 98: OvaGene Oncology Enters into Agreement with Etta Healthcare 211
Table 99: InTouch Health Enters into Agreement with iSchemaView 212
Table 100: Royal Philips Enters into Co-Development Agreement with Profound Medical 213
Table 101: Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 214
Table 102: Vivione Biosciences Enters into Distribution Agreement with Trillium Diagnostics 215
Table 103: GenomeDx Biosciences Enters into Agreement with Sidney Kimmel Cancer Center 216
Table 104: Natera Enters into Agreement with LifeLabs for Non-Invasive Prenatal Test 217
Table 105: Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 218
Table 106: PAML Enters into Co-Development Agreement with Axela 219
Table 107: DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test 220
Table 108: IncellDx Enters into Licensing Agreement with Claremont BioSolutions 221
Table 109: Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 222
Table 110: AngioDynamics Enters into Licensing Agreement with EmboMedics 223
Table 111: Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 224
Table 112: BioMark Diagnostics Enters into Agreement with Metabolomics Innovation Centre 225
Table 113: Biocartis Enters into Licensing and Development Agreement with Microbiome 226
Table 114: CBScientific Enters into Distribution Agreement with UTest 227
Table 115: GE Healthcare Enters into Agreement with Sunnybrook Health Sciences 228
Table 116: GeneThera Enters into Co-Development Agreement with Hudson Robotics 229
Table 117: Nanospeed Enters into Distribution Agreement with DiaSys for Test4D 230
Table 118: Genomic Vision Extends Agreement with Quest Diagnostics 231
Table 119: Caprion Enters into Licensing Agreement with Integrated Diagnostics for Xpresys Lung Test 233
Table 120: Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ 234
Table 121: Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 236
Table 122: BioMerieux Enters into Licensing Agreement with Astute Medical 237
Table 123: MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 238
Table 124: NoemaLife Enters into Distribution Agreement with Horiba Medical 239
Table 125: Good Start Genetics Enters into Agreement with IviGen and iGenomix 240
Table 126: Clinical Genomics Enters into Licensing Agreement with CSIRO 241
Table 127: Hangzhou Joinstar Biomedical Enters into Co-Development Agreement with Response Biomedical 242
Table 128: MedMira Enters into Co-Development Agreement with Beacon Biomedical 243
Table 129: AIT Austrian Institute Enters into Co-Development Agreement with BioVendor and Scienion 244
Table 130: BGI Forms Joint Venture with Vancouver Prostate Centre 245
Table 131: Ion Beam Applications Enters into Co-Development Agreement with Royal Philips 246
Table 132: Abcam Enters into Co-Marketing Agreement with Cell Marque for IVD IHC RabMAb Antibodies 247
Table 133: Ab Sciex Enters into Co-Development Agreement with Dalton Pharma 248
Table 134: Ohio State University and Nationwide Children’s Hospital Enter into Licensing Agreement with NTvantage Diagnostics 249
Table 135: Hibergene Diagnostics Enters into Licensing Agreement with Eiken for LAMP 250
Table 136: Xagenic Raises USD11.78 Million in Series B Financing 251
Table 137: ChipCare Raises USD4 Million in Series A Venture Financing 252
Table 138: GenePOC Raises Funds through Venture Financing 253
Table 139: Fio Raises USD0.7 Million in Venture Financing 254
Table 140: Proteocyte Diagnostics Raises USD0.55 Million in Venture Financing 255

List of Figures

Figure 1: In Vitro Diagnostics Market, Canada, Revenue ($m), USD Constant, 2007-2021 30
Figure 2: In Vitro Diagnostics Market, Canada, Revenue Mix ($m), 2014 32
Figure 3: In Vitro Diagnostics Market, Canada, Category Contribution (%), 2014 33
Figure 4: Vitro Diagnostics Market, Canada, Category Comparison by Revenue ($m), USD Constant, 2007-2021 34
Figure 5: In Vitro Diagnostics Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 36
Figure 6: In Vitro Diagnostics Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 38
Figure 7: In Vitro Diagnostics Market, Canada, Company Share (%) 2014 40
Figure 8: Clinical Chemistry Market, Canada, Revenue Mix ($m), 2014 42
Figure 9: Clinical Chemistry Market, Canada, Segment Contribution (%), 2014 43
Figure 10: Clinical Chemistry Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 45
Figure 11: Clinical Chemistry Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 47
Figure 12: Clinical Chemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 49
Figure 13: Therapeutic Drug Monitoring Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 51
Figure 14: Urine Analysis Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 53
Figure 15: Clinical Chemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 55
Figure 16: Therapeutic Drug Monitoring Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 57
Figure 17: Urine Analysis Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 59
Figure 18: Clinical Chemistry Market, Canada, Company Share (%) 2014 62
Figure 19: Genetic Testing Market, Canada, Revenue Mix ($m), 2014 64
Figure 20: Genetic Testing Market, Canada, Segment Contribution (%), 2014 65
Figure 21: Genetic Testing Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 66
Figure 22: Genetic Testing Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 68
Figure 23: Genetic Testing Market, Canada, Company Share (%) 2014 71
Figure 24: Haematology Market, Canada, Revenue Mix ($m), 2014 73
Figure 25: Haematology Market, Canada, Segment Contribution (%), 2014 74
Figure 26: Haematology Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 75
Figure 27: Haematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 77
Figure 28: Haematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 79
Figure 29: Haematology Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 81
Figure 30: Haematology Reagents Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 83
Figure 31: Haemostasis Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 85
Figure 32: Immunohaematology Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 87
Figure 33: Haematology Cell Counters Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 89
Figure 34: Haematology Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 91
Figure 35: Haematology Reagents Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 93
Figure 36: Haemostasis Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 95
Figure 37: Immunohaematology Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 97
Figure 38: Haematology Market, Canada, Company Share (%) 2014 100
Figure 39: Histology And Cytology Market, Canada, Revenue Mix ($m), 2014 102
Figure 40: Histology And Cytology Market, Canada, Segment Contribution (%), 2014 103
Figure 41: Histology And Cytology Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 104
Figure 42: Histology And Cytology Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 106
Figure 43: Histology And Cytology Market, Canada, Company Share (%) 2014 109
Figure 44: Immuno Chemistry Market, Canada, Revenue Mix ($m), 2014 111
Figure 45: Immuno Chemistry Market, Canada, Segment Contribution (%), 2014 112
Figure 46: Immuno Chemistry Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 114
Figure 47: Immuno Chemistry Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 116
Figure 48: Anemia Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 118
Figure 49: Disease Specific Immunochemistry Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 120
Figure 50: Endocrinology Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 122
Figure 51: IgE Allergy Blood Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 124
Figure 52: Immunochemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 126
Figure 53: Immunochemistry Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 128
Figure 54: Vitamins Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 130
Figure 55: Anemia Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 132
Figure 56: Disease Specific Immunochemistry Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 134
Figure 57: Endocrinology Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 136
Figure 58: IgE Allergy Blood Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 138
Figure 59: Immunochemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 140
Figure 60: Immunochemistry Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 142
Figure 61: Vitamins Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 144
Figure 62: Immuno Chemistry Market, Canada, Company Share (%) 2014 147
Figure 63: Infectious Diagnostics Market, Canada, Revenue Mix ($m), 2014 149
Figure 64: Infectious Diagnostics Market, Canada, Segment Contribution (%), 2014 150
Figure 65: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 152
Figure 66: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 154
Figure 67: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 156
Figure 68: Infectious Diagnostics Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 158
Figure 69: Infectious Diagnostics Market, Canada, Company Share (%) 2014 161
Figure 70: Microbiology Culture Market, Canada, Revenue Mix ($m), 2014 163
Figure 71: Microbiology Culture Market, Canada, Segment Contribution (%), 2014 164
Figure 72: Microbiology Culture Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 165
Figure 73: Microbiology Culture Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 167
Figure 74: Microbiology Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 169
Figure 75: Microbiology Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 171
Figure 76: Microbiology Culture Market, Canada, Company Share (%) 2014 174

Published By: GlobalData
Product Code: GlobalData32857


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we´┐Żll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Medical Devices market as per your needs. Get the best of Medical Devices research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest: